From Blue Water to Red Ink

Today, I'm looking at Leslie’s, Inc. (LESL), the biggest pool and spa retailer in the U.S. that's had a surprisingly rough go of it in recent years.

Here are a few things that stood out:

• Recurring engine: Over 80% of their assortment is consumables like chemicals—recurring purchases with natural seasonality.

• Private-label muscle: More than half of sales are from owned/exclusive brands, a structural margin lever.

• Diagnostic ritual: Their free “AccuBlue” water testing funnels people straight to the right basket of products.

• Distribution reach: 1,000+ locations plus e-commerce and PRO counters keep them close to customers.

• But… margins are leaking: Gross margin slid from ~43% in 2022 to ~34.6% TTM while operating profit has dropped from ~$239M to ~$7M over the same period . Inventory write-downs, chemical price resets, and occupancy costs have hit hard.

With a market cap of $52M and $700M+ of debt, Leslie is currently trading like it's going to have any equity value left in the not-too-distant future.

Given that they own a lot of their stores and have proprietary brands, it's surprising to see just how bad their margins have gotten. My research indicates that they bought a lot of inventory during the supply chain crunch of 2020-2022 and simply couldn't maintain their prices as they had to sell that inventory through. There's crushed margins.

If you told me what this business did and the recurring nature of their products, I would have assumed much better financials for them today. But it just goes to show how tough it's been when it comes to consumer discretionary spending over the last couple of years.

All in all, this is a tale that you need to be especially cautious when making sizable input purchases. At the same time, have any respect that recurring maintenance can become more optional in the future than what you might think, adding fragility to a recurring heavy business.

With that, I'll see you tomorrow!

Nick

TL;DR

• Largest direct-to-consumer pool and spa care retailer in the United States, selling chemicals, equipment, parts, and services through 1,000+ stores plus e-commerce.

• Key insight: recurring essentials can be powerful, but mix shifts and margin compression can erase operating leverage fast.

• Strengths: local distribution, private-label breadth, and diagnostic services like in-store water testing.

• Weak spots: low switching costs on product, intense price competition, weather seasonality, and debt load.

• Operator lesson: build a diagnostic ritual and private-label engine, then defend gross margin with discipline.

The 30,000-Foot View

• Business model: Specialty retail focused on aftermarket pool and spa needs. Monetizes recurring consumables, equipment, and services. Water testing funnels customers to precise prescriptions in-store and online.

• Revenue sources and mix: Chemicals are the plurality driver. Owned and exclusive brands exceed 55% of sales. More than 80% of the assortment is non-discretionary consumables. Category mix is not recently disclosed, but chemicals historically carried a ~45% share.

• Key stats (as of FY2024 and recent TTM):

  • Market cap: ~$52 million as of Sep 19, 2025.

  • TTM revenue: ~$1.25 billion. TTM gross margin: ~34.6%. TTM net loss: ~$84 million.

  • Employees: ~3,850 as of FY2024.

  • Industry: Consumer Discretionary, Specialty Retail.

• So what for founders: This is a repeat-purchase category where private-label and services matter more than one-off promos. The game is basket size, replenishment cadence, and tight inventory turns.

Company History

• 1963: Founded by Phil Leslie Jr., first store in Los Angeles.

• 1997: Taken private via LBO. Ownership cycles among private equity sponsors follow.

• 2017: Acquired by L Catterton.

• 2020: Returns to public markets on Nasdaq under ticker LESL, IPO at $17.

• 2022-2023: Post-pandemic normalization, chemical price deflation and inventory clean-ups pressure margin.

• Sep 2024: CEO transition to Jason McDonell.

• FY2024: Sales ~$1.33 billion, net loss, margin compression continues.

• 2025: Credit ratings downgraded and sub-$1 share price raises listing-compliance risk.

Show Me the Money

Stand-out financial features

• Private-label is a structural margin lever at 55%+ of sales.

• Essentials-heavy SKU mix, with >80% non-discretionary products, drives repeat behavior.

• Gross margin down from ~43% in FY2022 to ~34.6% TTM, driven by chemical price resets, occupancy deleverage, and inventory adjustments.

• Interest burden and leverage curb flexibility. Term debt and revolver usage weigh on earnings.

• Inventory reductions and working-capital focus improved cash flow in FY2024.

Financial Data

The N.O.O.B. Nine — Competitive Powers

The Nerd Out on Business Nine is made up of Hamliton Helmer's famous "7 Powers" of competitive advantage (Scale Economies, Network Economies, Counter-Positioning, Switching Costs, Branding, Cornered Resource, and Process Power) combined with two of my own (Data Flywheel and Distribution Advantage).

Average Score: 2.8/5 - A middling moat built on footprint, private-label, and service rituals, not lock-in or network effects.

Memorable Marketing

Overall approach: Sell reassurance, not chlorine. Leslie's leans on expert positioning, free diagnostics, loyalty rewards, and private-label value, then fulfills across store, app, and web.

• Pool Perks (ongoing)

  • Hook: Cash-back rewards and targeted offers that keep customers in the Leslie's loop.

  • Channels: email, app, POS, site.

  • Why it worked: Rewards tied to maintenance cycles create habit and raise LTV.

  • Result: A larger direct base and higher retention, with loyalty as a major driver of repeat purchases.

• AccuBlue Free Water Test (upgraded 2022-2024)

  • Hook: Bring a sample, leave with a precise prescription and the right basket.

  • Channels: in-store service, site content, app.

  • Why it worked: Diagnostic ritual raises conversion and basket size while reinforcing expertise.

  • Result: Higher engagement and LTV, plus a cleaner funnel into private-label consumables.

• AccuBlue Home (2022-2024)

  • Hook: At-home testing guided by Leslie's prescription logic.

  • Channels: e-commerce, email, content.

  • Why it worked: Convenience plus data capture enables timed replenishment prompts.

  • Result: Extends the testing-to-cart loop beyond the store, capturing more of the maintenance cycle.

• PRO Partner (ongoing)

  • Hook: Dedicated counters, assortments, and perks for service pros.

  • Channels: in-store PRO counters, B2B email, inside sales.

  • Why it worked: Saves time for pros who value availability and speed.

  • Result: More resilient B2B demand even when retail softens.

Tactical takeaways

• Build a diagnostic ritual that naturally sells the basket in your category.

• Push private-label where you can control specs, price points, and margin.

• Turn replenishment into a habit with loyalty tiers and timed reminders.

• Carve out a PRO lane with service promises and inventory that save time.

• Tie content and offers to maintenance cadences, then automate the nudges.

AI Uses & Opportunities

• What exists today: AccuBlue software uses historical water-test data to recommend dosing and products. This functions as decision support and a targeting engine.

• What to add next:

  • Hyperlocal demand forecasting using weather, housing turnover, and store-level service logs to plan labor and inventory.

  • Adaptive replenishment and dynamic pricing for private-label chemicals based on pool counts by ZIP and recent test anomalies.

  • Guided service triage for staff and pros, using LLMs that ingest symptoms, test histories, and equipment telemetry.

  • UGC-to-ads pipeline that mines reviews and community posts for ad copy, then auto-tests variants on paid channels.

  • Vision-based quality checks and pick-pack verification in distribution to cut shrink and returns.

Bumps in the Road

• Margin reset and traffic softness. FY2023 gross margin fell sharply on chemical price resets, inventory and rebate adjustments, and occupancy deleverage.

• Profitability pressure. FY2024 revenue slipped to ~$1.33 billion with a net loss. TTM operating margin sits near breakeven.

• Balance sheet and ratings. Term loan and revolver usage add interest drag. Ratings downgrades in 2025 limit flexibility.

• Listing-compliance risk. Sub-$1 share price raises reverse-split and Nasdaq minimums risk.

• Weather and seasonality. Cool or rainy summers reduce chemical consumption and big-ticket demand.

• Channel competition. Big-box, marketplaces, and local independents compete on convenience and price.

Your Swipe File

• Design a diagnostic on-ramp that makes the purchase obvious after the test or audit.

• Build margin with private-label and service, not coupons.

• Guard your gross margin drivers and scenario-plan for deflation or mix shifts.

• If your category is seasonal, do inventory and staffing math early to avoid deleverage.

• Loyalty is a habit machine, not a moat. Keep feeding it with useful, timed nudges.